Publications by authors named "Nuy Chau"

Claim this Profile
T
The molecular basis of dapsone activation of CYP2C9-catalyzed nonsteroidal anti-inflammatory drug oxidation.
Pramod C Nair, Kushari Burns, Nuy Chau, Ross A McKinnon, John O Miners

J Biol Chem· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Arginine-259 of UGT2B7 Confers UDP-Sugar Selectivity.
Pramod C Nair, Nuy Chau, Ross A McKinnon, John O Miners

Mol Pharmacol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202.
Porntipa Korprasertthaworn, Nuy Chau, Pramod C Nair, Andrew Rowland, John O Miners

Biochem Pharmacol· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug and Chemical Glucosidation by Control Supersomes and Membranes from (Sf) 9 Cells: Implications for the Apparent Glucuronidation of Xenobiotics by UDP-glucuronosyltransferase 1A5.
Nuy Chau, Leyla Kaya, Benjamin C Lewis, Peter I Mackenzie, John O Miners

Drug Metab Dispos· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.
John O Miners, Nuy Chau, Andrew Rowland, Kushari Burns, Ross A McKinnon

Biochem Pharmacol· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaling factors for the in vitro-in vivo extrapolation (IV-IVE) of renal drug and xenobiotic glucuronidation clearance.
Kathleen M Knights, Shane M Spencer, John K Fallon, Nuy Chau, Philip C Smith

Br J Clin Pharmacol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of Human UDP-Glucuronosyltransferase Enzymes by Canagliflozin and Dapagliflozin: Implications for Drug-Drug Interactions.
Attarat Pattanawongsa, Nuy Chau, Andrew Rowland, John O Miners

Drug Metab Dispos· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Morphine glucuronidation and glucosidation represent complementary metabolic pathways that are both catalyzed by UDP-glucuronosyltransferase 2B7: kinetic, inhibition, and molecular modeling studies.
Nuy Chau, David J Elliot, Benjamin C Lewis, Kushari Burns, Martin R Johnston

J Pharmacol Exp Ther· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ketamine on human UDP-glucuronosyltransferases in vitro predict potential drug-drug interactions arising from ketamine inhibition of codeine and morphine glucuronidation.
Verawan Uchaipichat, Pritsana Raungrut, Nuy Chau, Benjamas Janchawee, Allan M Evans

Drug Metab Dispos· August 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The novel UDP glycosyltransferase 3A2: cloning, catalytic properties, and tissue distribution.
Peter I MacKenzie, Anne Rogers, David J Elliot, Nuy Chau, Julie-Ann Hulin

Mol Pharmacol· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Marked reduction in obstructive sleep apnea severity in slow wave sleep.
Rajeev Ratnavadivel, Nuy Chau, Daniel Stadler, Aeneas Yeo, R Doug McEvoy

J Clin Sleep Med· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis